-
- This site reveals that the U.S. Department of Energy's
Argonne National Laboratory announced June 29, 1998 a joint-research project
with Motorola Inc. and Packard Instrument Company "which aims at commercializing
and marketing advanced biochips and related analytical technologies...."
Take note--this partnership of powers was "announced" June 29,
1998. At this posting (Oct. 1999), that was over a year and three months
ago. Just think of the research that had to have preceeded this agreement
in order for these three entities to have formed this partnership.
-
- You'll see the site states "Motorola will develop
manufacturing processes to mass produce biochips, and Packard will develop
and manufacture the analytical instruments to process and analyze the biochips."
Take note--MASS PRODUCE BIOCHIPS. The United States government has entered
into an agreement with two publicly held corporations to MASS PRODUCE BIOCHIPS
and no one has informed the American public!
-
- The site further states, "Argonne's contribution,
in conjunction with its Moscow research partner the Russian Academy of
Science's Engelhardt Institute of Molecular Biology, is intellectual property
in the form of 19 inventions related to biological microchips." The
irony here is that our government has been co-inventing technology with
RUSSIA that we, the American people, can not get information on because
it is classified under of National Security!
-
- Take note when you read "The Argonne/Engelhardt
biochips employ a novel "micro-gel" technology in which as many
as 10,000 micro-structures are mounted on a single glass surface about
the size of a microscopic slide." What they are not telling you is
that this "micro-gel", aka the biochip, can be put into a liquid
and injected into a human body via an injection--a flu shot, any childhood
immunization, etc. This site promotes "the great diagnostic powers
this technology will bring to fields as diverse as medicine and environmental
restoration," but fails to inform the reader of hidden dangers.
-
- The site makes reference to the Russian Human Genome
Program and the Department of Energy's Human Genome Program. According
to a biologist who works on the Department of Energy's Genome Program,
part of the project's "research" includes experimenting on the
general public with aireal spraying. For more information on how this aireal
spraying ties in with the biochips, refer to the information contained
in the video and audios listed in the products section.
-
- PARTNERSHIP TO DEVELOP BIOCHIP TECHNOLOGY
-
- http://www.osti.gov/biochip.htm
-
- Motorola, Packard Instrument Co. and Argonne to develop
advanced biochip technology
-
- http://www.anl.gov/OPA/news98/news980629.htm
-
- ARGONNE, Ill. (June 29, 1998)
-- Rapid advances in medicine, health care and agriculture are expected
from a joint-research project announced today byMotorola Inc.,Packard Instrument
Company and the U.S. Department of Energy's Argonne National Laboratory.
-
- The project, which aims at commercializing and marketing
advanced biochips and related analytical technologies, is expected to make
the process of decoding genes, human or otherwise, a thousand times faster
than with current technologies.
-
- Motorola will develop manufacturing processes to mass
produce biochips, and Packard will develop and manufacture the analytical
instruments to process and analyze the biochips. Argonne's contribution,
in conjunction with its Moscow research partner the Russian Academy of
Science's Engelhardt Institute of Molecular Biology, is intellectual property
in the form of 19 inventions related to biological microchips.
-
- Motorola and Packard will contribute a total of $19 million
over five years to support the joint-research agreement, making it one
of the largest biotechnology joint-research agreements ever signed by a
U.S. Department of Energy laboratory. Argonne's 19 inventions, which have
been licensed exclusively to Motorola and Packard, are the result of more
than $10 million in research support since 1994 by the U.S. Department
of Energy, theDefense Advanced Research Projects Agency, the Russian Academy
of Sciences, and the Russian Human Genome Program.
-
- "With a commercial biochip to rapidly and economically
perform genetic analysis, within a few years we should see better pharmaceuticals
developed more rapidly, faster and more accurate medical diagnostics, a
heightened ability to assess and possibly repair environmental damage,
and better, more hardy, and healthier crops," said Richard McKernan,
president of Packard Instrument Company.
-
- "This process, developed for the Department of Energy's
human genome program, provides miniaturized, faster and more economical
methods to analyze DNA samples," said Secretary of Energy Federico
PeÒa. "Today's announcement is a recognition of the great diagnostic
powers this technology will bring to fields as diverse as medicine and
environmental restoration."
-
- Like computer chips, which perform millions of mathematical
operations a second, biochips can perform thousands of biological reactions,
such as decoding genes, in a few seconds.
-
- The Argonne/Engelhardt biochips employ a novel "micro-gel"
technology in which as many as 10,000 micro-structures are mounted on a
single glass surface about the size of a microscopic slide.
-
- Each micro-gel is like a micro-test tube in which chemical
compounds can be tested against biological targets to provide answers to
questions about DNA sequence, genetic variation, gene expression, protein
interaction and immune response.
-
- In addition to being faster than conventional gene sequencing
methods, these biochips provide a 3-dimensional platform that allows greater
sensitivity and accuracy in assaying proteins, RNA and DNA.
-
- "Instead of reading DNA one letter or word at a
time, they read whole phrases and sentences at a time," said Andrei
Mirzabekov, a biologist whose research at Argonne and Engelhardt developed
the biochips. "It's like speed-reading the genetic code with one hundred
percent comprehension.
-
- "By combining biochips with robots and computers,"
Mirzabekov said, "we can find one genetic variation among three billion
DNA bases in a matter of minutes. Conventional methods take days."
A DNA base is one of the four biological molecules that link together to
form DNA's well-known "double-helix" molecule.
-
- "Over the next four or five years, we plan to develop
and refine the technology to mass produce biochips," said Rudyard
L. Istvan, Motorola vice president and corporate director of strategy.
"This should reduce their cost and make them widely available to genetic
researchers in many fields."
-
- "Packard is known throughout the pharmaceutical
and life sciences markets for providing innovative tools to speed drug
discovery research," said McKernan. "As part of this team, we
will develop the analytical instrumentation needed to use and process biochips."
-
- This biotechnology will have myriad applications in life
science, including medical diagnostics, drug discovery, environmental restoration
and agriculture.
-
- Medical diagnostics is where the greatest impact is expected.
Medical and biological researchers will be able to identify in minutes
mutated genes that could lead to later medical problems, such as cancer,
multiple sclerosis or Alzheimer's. Widespread use of biochips will also
remove the guesswork from early treatment of many diseases and conditions.
By using less than a drop of test solution, doctors will be able to predict
drug efficacy, to diagnose drug resistance to treatment for diseases such
as AIDS and tuberculosis, and to make on-the-spot identification of specific
bacteria, viruses, and other micro-organisms.
-
- Faster drug discovery and improved medical treatmentwill
result from the ability to identify target genes and test new drugs and
treatments far more rapidly for possible genetic impact. Bioassays that
determine whether a drug causes genetic mutations or has other hazardous
effects can be completed in days, rather than weeks or months. The use
of biochips is also expected to speed up the regulatory drug approval process
by classifying patient population based on genetic makeup.
-
- Faster progress in life-sciences research will result.
For example, the regulation of gene expression, which takes months to study
with conventional sequencing techniques, can be accomplished in a single,
parallel experiment with this biochip technology.
-
- Faster and more effective environmental restoration will
result from the ability to use biochips as highly sensitive detectors of
microbial or organic pollution. Biochips may also help identify genes that
enable some natural enzymes to detoxify chemicals and digest pollutants.
Once identified, these environmentally friendly genes can be transferred
into common bacteria to help clean up contaminated earth or water.
-
- Improved agricultural products will result from the ability
to quickly and accurately detect agricultural disease and mutation, and
to speed tests of the safety of new agricultural products. For example,
genes that help plants resist mold can be identified and transferred to
crops attacked by mold.
-
- Motorola is one of the world's leading providers of wireless
communications, semiconductors and advanced electronic systems, components
and services. Major equipment businesses include paging and data communications,
cellular telephone, two-way radio,personal communications, automotive,
defense and space electronics and computers. Motorola semiconductors power
communications devices, computers and millions of other products. Motorola's
1997 sales were $29.8 billion.
-
- Packard Instrument Company is a subsidiary of Packard
BioScience Company, a privately held company based in Meriden, Conn. Packard
develops, manufactures and distributes innovative, high-quality analytical
instrumentation, liquid-handling robots, and reagents. A premier supplier
to the world's leading pharmaceutical and biotechnology companies, Packard
provides the tools to make the search for cures for diseases faster, safer
and more cost effective.
-
- With more than 200 different programs in basic and applied
research, Argonne is one of the nation's largest federally funded scientific
laboratories. Argonne is is operated by the University of Chicago for the
U.S. Department of Energy.
-
- For more information, please contact:
-
- For Argonne
- Catherine Foster
- 630/252-5580
- cfoster@anl.gov
-
- For Packard
- Mary Ann Dostaler
- 860/688-5452
- madcom@concentric.net
-
- For Motorola
- Kerry Kelly
- Cunningham Communication Inc.
- 617/374-4254
- kkelly@ccipr.com
-
- FROM SURFING THE APOCALYPSE
- http://www.surfingtheapocalypse.com
-
-
-
- RMNews, The Uncensored National Rumor
- http://www.rumormillnews.com
- THE ONLY RUMOR YOU CAN TRUST
-
- RUMOR MILL NEWS AGENCY
- P.O. BOX 1784
- APTOS, CA 95001
- TELFAX 831 462 3949
-
-
-
- SIGHTINGS HOMEPAGE
http://www.sightings.com
- This
Site Served by TheHostPros
|